Does AMBROXOL Cause Mobility decreased? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Mobility decreased have been filed in association with AMBROXOL. This represents 2.1% of all adverse event reports for AMBROXOL.
19
Reports of Mobility decreased with AMBROXOL
2.1%
of all AMBROXOL reports
0
Deaths
19
Hospitalizations
How Dangerous Is Mobility decreased From AMBROXOL?
Of the 19 reports, 19 (100.0%) required hospitalization, and 17 (89.5%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBROXOL. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does AMBROXOL Cause?
Dyspnoea (169)
Drug ineffective (149)
Cough (141)
Off label use (138)
Chest discomfort (134)
Nasopharyngitis (128)
Atrial fibrillation (125)
Dyspnoea exertional (122)
Dysphonia (121)
Wheezing (121)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which AMBROXOL Alternatives Have Lower Mobility decreased Risk?
AMBROXOL vs AMDINOCILLIN PIVOXIL
AMBROXOL vs AMG-510
AMBROXOL vs AMIFAMPRIDINE
AMBROXOL vs AMIFOSTINE
AMBROXOL vs AMIKACIN